Is WENA or DIVO a better dividend investment in 2026?

WENA currently yields 275.48% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: WENA offers higher current income.

What is the dividend yield difference between WENA and DIVO?

WENA has a forward dividend yield of 275.48% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 268.99 percentage points.

Home › Compare › WENA vs DIVO

WENA vs DIVO: Dividend Comparison 2026

WENA yields 275.48% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 WENA wins by $860.04M in total portfolio value

INVESTMENT

TIME HORIZON10 years

WENA

● Live price

275.48%

Share price

$0.73

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$860.08M

Annual income

$501,772,088.45

Full WENA calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — WENA vs DIVO

📍 WENA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	WENA	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, WENA + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

WENA pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

WENA

Annual income on $10K today (after 15% tax)

$23,415.98/yr

After 10yr DRIP, annual income (after tax)

$426,506,275.18/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, WENA beats the other by $426,505,440.75/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of WENA + DIVO for your $10,000?

WENA: 50%DIVO: 50%

100% DIVO50/50100% WENA

Portfolio after 10yr

$430.05M

Annual income

$250,886,535.07/yr

Blended yield

58.34%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

WENA buys

DIVO buys

No recent congressional trades found for WENA or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricWENADIVO

Forward yield	275.48% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$860.08M ✓	$30.7K
Annual income after 10y	$501,772,088.45 ✓	$981.68
Total dividends collected	$823.11M ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: WENA vs DIVO ($10,000, DRIP)

Year	WENA Portfolio	WENA Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$38,248	$27,548.21	$11,349	$649.42	+$26.9K → WENA
2	$139,399	$98,473.80	$12,833	$688.83	+$126.6K → WENA
3	$484,576	$335,418.24	$14,459	$727.90	+$470.1K → WENA
4	$1,608,187	$1,089,691.52	$16,238	$766.49	+$1.59M → WENA
5	$5,100,591	$3,379,830.49	$18,179	$804.47	+$5.08M → WENA
6	$15,475,954	$10,018,322.01	$20,293	$841.71	+$15.46M → WENA
7	$44,967,761	$28,408,489.97	$22,591	$878.14	+$44.95M → WENA
8	$125,260,578	$77,145,073.44	$25,087	$913.65	+$125.24M → WENA
9	$334,862,969	$200,834,150.89	$27,791	$948.18	+$334.84M → WENA
10	$860,075,466	$501,772,088.45	$30,718	$981.68	+$860.04M → WENA

WENA vs DIVO: Complete Analysis 2026

WENA — Stock

Anew Medical, Inc., a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors. The company has a strategic partnership with Japan's Okinawa Research Center for the research and development of Klotho gene therapy in enhancing longevity and reducing age-related diseases. Anew Medical, Inc. is based in Omaha, Nebraska.

Full WENA Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this WENA vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

WENA vs SCHD WENA vs JEPI WENA vs O WENA vs KO WENA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.